DRUG RECALL ALERT - Recall of Chantix by Pfizer
September 22, 2021
Pfizer announced a voluntary consumer-level recall of all lots of Chantix (varenicline) tablets due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable daily intake limit.
Clinical Services will be conducting a drug recall mailing to potentially impacted members and providers. Below are mailing details.
Recall identification date
Look back period
Target population for clinical mailing
Fulfillment due date for NCQA compliance
0069-0468-56; 0069-0469-56; 0069-0469-03; 0069-0471-03
5/19/2021 – 9/17/2021
Mailing: Members; Direct Message/Fax: Providers
On or before: 10/07/21